文献速递皮肤肿瘤

远程皮肤科用于皮肤癌诊断与管理的系统综述

Teledermatology for the Diagnosis and Management of Skin Cancer: A Systematic Review.
PubMed 文献 · JAMA Dermatol · 2017-01-01

面对面诊断与参考标准的一致率为67%-85%(κ=0.90),远程皮肤科为51%-85%(κ=0.41-0.63),但部分研究报告远程诊断准确性高。远程皮肤科可缩短等待时间并提高患者满意度,但诊断准确性研究存在显著方法学局限。

要点

  • 面对面皮肤科诊断皮肤癌的准确性高于远程皮肤科,但部分远程研究准确性高。
  • 远程皮肤科可缩短患者等待评估和治疗的时间,患者满意度高且愿意自费。
  • 现有诊断准确性研究存在显著方法学局限,需更严谨的实施研究。

核心结论

  • 远程皮肤科诊断皮肤癌的准确性(与参考标准一致率51%-85%,κ=0.41-0.63)低于面对面诊断(一致率67%-85%,κ=0.90),但部分研究报告远程诊断准确性高。
  • 远程皮肤科可缩短等待时间并提高患者满意度,但诊断准确性研究存在显著方法学局限。

研究设计与样本

  • 系统综述,检索Cochrane、PubMed、Medline、Science Direct、Embase和Web of Science六个数据库。

主要发现

  • 面对面皮肤科诊断皮肤癌与参考标准的一致率为67%-85%(κ=0.90)。
  • 远程皮肤科诊断皮肤癌与参考标准的一致率为51%-85%(κ=0.41-0.63)。
  • 部分研究报告远程皮肤科诊断准确性高。
  • 远程皮肤科可缩短等待时间,可能实现更早评估和治疗。
  • 患者报告高满意度并愿意自费获取远程皮肤科服务。

临床怎么用

  • 远程皮肤科可用于缩短皮肤癌评估和诊断的等待时间。
  • 在临床实践中采用远程皮肤科诊断皮肤癌时,需注意其诊断准确性可能低于面对面诊断。
  • 患者对远程皮肤科服务满意度高,且愿意自费使用。

局限性

  • 大多数诊断准确性和一致性研究存在显著方法学局限。
  • 需开展稳健的实施研究,并注意降低诊断准确性评估中的偏倚风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: As technology becomes more commonplace in dermatological practice, it is essential to continuously review the accuracy of teledermatology devices and services compared with in-person care. The last systematic review was conducted over 5 years ago. OBJECTIVE: To synthesize and assess the quality of the evidence to address 3 research questions: (1) How accurate is teledermatology for skin cancer diagnosis compared with usual care (face-to-face [FTF] diagnosis)? (2) Does teledermatology save clinician and/or patient time, compared with usual care? (3) What are the enablers and barriers to adoption of teledermatology in clinical practice for the diagnosis of skin cancer? EVIDENCE REVIEW: The review protocol was registered in the PROSPERO database. Six databases (Cochrane, PubMed, Medline, Science Direct, Embase, and Web of Science) were searched for studies investigating the diagnostic accuracy and concordance, management accuracy and concordance, measures of time (waiting times, delay to diagnosis), and enablers and barriers to implementation. Potentially eligible articles were screened by 2 reviewers. The Quality Assessment of Diagnostic Accuracy Studies (QUADAS-2) tool was used to evaluate the risk of bias and applicability of individual studies assessing diagnostic accuracy. FINDINGS: Twenty-one studies were reviewed. The diagnostic accuracy (defined as agreement with histopathology for excised lesions or clinical diagnosis for nonexcised lesions) of FTF dermatology consultation remains higher (67%-85% agreement with reference standard, Cohen κ, 0.90) when compared with teledermatology (51%-85% agreement with reference standard, κ, 0.41-0.63), for the diagnosis of skin cancer. However, some studies do report high accuracy of teledermatology diagnoses. Most studies of diagnostic accuracy and concordance had significant methodological limitations. Studies of health service outcomes found teledermatology reduced waiting times and could result in earlier assessment and treatment. Patients reported high satisfaction and were willing to pay out of pocket for access to such services. CONCLUSIONS AND RELEVANCE: Robust implementation studies of teledermatology are needed, paying careful attention to reducing risk of bias when assessing diagnostic accuracy. Teledermatology services consistently reduced waiting times to assessment and diagnosis, and patient satisfaction was high.

来源:JAMA Dermatol,查看原文。版权归原作者所有。

引用

  1. Finnane A, Dallest K, Janda M, et al. Teledermatology for the Diagnosis and Management of Skin Cancer: A Systematic Review. JAMA Dermatol. 2017. PMID: 27926766. doi:10.1001/jamadermatol.2016.4361

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。